Alkem

{{ Form::open(['url' => '#', 'name' => 'validateForm', 'id' => 'validateForm', 'enctype' => 'multipart/form-data']) }}

Back

PPIs Survey

A nationwide, multicenter cross sectional, observational, questionnaire-based survey to assess physician's perspectives towards the utilization of Proton Pump Inhibitors (PPIs)

Name of Doctor *

{{--

--}}

Address *

Speciality *

Email ID *

Mobile Number *

The questions to be answered by the general physicians. Following are questions:

How often do you encounter patients with comorbidities who are on polypharmacy? *

Rarely Occasionally Frequently Very frequently I do not encounter such patients

In your experience, what percentage of these patients report gastrointestinal symptoms (heartburn, reflux, epigastric pain, etc.) related to their medication regimen? *

None Less than 25% 25-50% 51-75% More than 75% Not applicable/I do not ask about gastrointestinal symptoms Not applicable/I do not encounter such patients

In your opinion, what are the criteria while selecting a PPI? (Choose 1 or >1 option) *

Symptom severity Patient's comorbidities Drug interactions Potential adverse effects Cost and accessibility Patient preference Previous response to PPI therapy Guidelines and evidence-based recommendations

Which PPI do you often prescribe, keeping in mind drug interactions in comorbid patient? *

Pantoprazole Esomeprazole Rabeprazole Omeprazole Lansoprazole

Are there specific comorbidities or medications that influence your decision to prescribe PPIs? *

What is your typical duration of PPI therapy for patients with comorbidities and polypharmacy? *

Less than 4 weeks 4 to 8 weeks 8 to 12 weeks 12 weeks to 6 months More than 6 months I do not typically prescribe PPI therapy

Do you routinely reassess the need for PPI therapy or consider discontinuation in certain cases? *

Yes No

What are your primary concerns regarding the long-term use of PPIs in patients with comorbidities and polypharmacy? *

How do you monitor the effectiveness of PPI therapy in these patients? *

Are there any specific guidelines or recommendations you would like to see regarding PPI use in this patient population? *

@include('user.footer')